Management of chronic pain with chronic opioid therapy in patients with substance use disorders

被引：41

作者：

Chang Y.-P. ^{[1
]}

Compton P. ^{[2
]}

机构：

[1] University of Buffalo School of Nursing, Buffalo, Wende Hall 201E, 3435 Main Street, Buffalo, 14221, NY

[2] School of Nursing and Health Studies, Georgetown University, Washington, DC

来源：

Addiction Science & Clinical Practice | / 8卷 / 1期

基金：

美国国家卫生研究院;

关键词：

Addiction/substance use disorder; Chronic opioid therapy; Chronic pain; Relapse prevention;

D O I：

10.1186/1940-0640-8-21

中图分类号：

学科分类号：

摘要：

Substance use disorders (SUDs), whether active or in remission, are often encountered in patients with chronic nonmalignant pain. Clinicians are challenged when managing chronic pain while facing substance abuse issues during the course of chronic opioid therapy (COT). Further, the interrelated behavioral symptomatology of addiction and chronic pain suggests that if one disorder is untreated, effective treatment of the other in not possible. Incomplete understanding of the overlapping presentations of the two disorders, coupled with insufficient management of both conditions, leads to undertreated pain and premature discharge of SUD patients from pain treatment. In order to achieve pain relief and optimal functionality, both conditions need to be carefully managed. This paper reviews the prevalence of SUDs in chronic pain patents; the overlapping presentation of the two disorders; risk factors and stratification for addiction; identification of addiction in the chronic pain population; and suggestions for treating patients with COT, with an emphasis on relapse prevention. With appropriate assessment and treatment, COT for chronic pain patients with a history of SUD can be successful, leading to improved functionality and quality of life. © 2013 Chang and Compton; licensee BioMed Central Ltd.

引用

共 78 条

[1]

Dobscha S.K., Corson K., Flores J.A., Tansill E.C., Gerrity M.S., Veterans affairs primary care clinicians' attitudes toward chronic pain and correlates of opioid prescribing rates, Pain Med, 9, 5, pp. 564-571, (2008)

[2]

Keller C.E., Ashrafioun L., Neumann A.M., Van Klein J., Fox C.H., Blondell R.D., Practices, perceptions, and concerns of primary care physicians about opioid dependence associated with the treatment of chronic pain, Subst Abus, 33, 2, pp. 103-113, (2012)

[3]

Upshur C.C., Luckmann R.S., Savageau J.A., Primary care provider concerns about management of chronic pain in community clinic populations, J Gen Intern Med, 21, 6, pp. 652-655, (2006)

[4]

Naliboff B.D., Wu S.M., Pham Q., Clinical considerations in the treatment of chronic pain with opiates, J Clin Psychol, 62, 11, pp. 1397-1408, (2006)

[5]

Wolfert M.Z., Gilson A.M., Dahl J.L., Cleary J.F., Opioid analgesics for pain control: Wisconsin physicians' knowledge, beliefs, attitudes, and prescribing practices, Pain Med, 11, 3, pp. 425-434, (2010)

[6]

Portenoy R.K., Savage S.R., Clinical realities and economic considerations: Special therapeutic issues in intrathecal therapy-tolerance and addiction, J Pain Symptom Manage, 14, 3, pp. S27-S35, (1997)

[7]

Morasco B.J., Gritzner S., Lewis L., Oldham R., Turk D.C., Dobscha S.K., Systematic review of prevalence, correlates, and treatment outcomes for chronic non-cancer pain in patients with comorbid substance use disorder, Pain, 152, 3, pp. 488-497, (2011)

[8]

Diagnostic and Statistical Manual of Mental Disorders, (2013)

[9]

Katz N.P., Adams E.H., Chilcoat H., Colucci R.D., Comer S.D., Goliber P., Grudzinskas C., Jasinski D., Lande S.D., Passik S.D., Schnoll S.H., Sellers E., Travers D., Weiss R., Challenges in the development of prescription opioid abuse-deterrent formulations, Clin J Pain, 23, pp. 648-660, (2007)

[10]

Savage S.R., Joranson D.E., Covington E.C., Schnoll S.H., Heit H.A., Gilson A.M., Definitions related to the medical use of opioids: Evolution towards universal agreement, J Pain Symptom Manage, 26, 1, pp. 655-667, (2003)

← 1 2 3 4 5 6 7 8 →